Welcome to the e-CCO Library!

P038: Revised roles of matrix metalloproteinase/MMP-9 in inflammatory bowel diseases: from target to biomarker
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. de Bruyn*1, 2, C. Breynaert3, I. Arijs2, G. De Hertogh4, K. Geboes4, G. Thijs1, J. Hu5, J. Van Damme1, B. Arnold6, M. Ferrante7, S. Vermeire7, G. Van Assche7, J. Ceuppens3, G. Opdenakker1

Created: Friday, 22 February 2019, 9:49 AM
P038: Targeting the hepcidin-ferroportin axis with Nrf2 agonists to treat iron deficiency anaemia in Inflammatory Bowel Disease
Year: 2022
Source: ECCO'22
Authors: Martin, J.(1,2);Aksan, A.(1,2,3);Steinhilber, D.(2);Ulrich-Rückert, S.(1,2);Stein, J.M.(1,2,4);
Created: Friday, 11 February 2022, 3:52 PM
P038: Th17 cells dominate the colonic mucosal immune response in primary sclerosing cholangitis associated colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

M.N. Quraishi1,2,3*, A. Acharjee2,4, E. Liaskou1, A. Rossiter5, C. Tselepis4, G. Gkoutos2,4, S. Ghosh2,3, G. Hirschfield1, D. Withers6, T.H. Iqbal2,3

Created: Thursday, 21 February 2019, 9:14 AM
P038: Tissue differences in the pro-inflammatory activation of ER stress of patients with Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Coope A.*1, Botezelli J.D.2, Bitencourt Pascoal L.1, Ramos Silva F.1, Ayrizono M.L.S.1, Milanski M.2, Velloso L.A.3, Leal R.F.1

Created: Wednesday, 20 February 2019, 10:36 AM
P039 has been withdrawn.:
Year: 2018
Source: ECCO '18 Vienna
Authors:

Created: Thursday, 21 February 2019, 9:14 AM
P039 Regional distribution of TCR Vδ1 and TCR Vδ2 cells in healthy and inflamed mucosa of inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E. Tristan, A. Carrasco, A. Martín-Cardona, Y. Zabana, M. Aceituno, D. Horta, X. Andújar, I. Salvador, C. Loras, F. Fernández-Bañares, M. Esteve

Created: Thursday, 30 January 2020, 10:12 AM
P039: Expression of the liver homing receptor CXCR3+ on colonic CD8+ T lymphocytes in patients with primary sclerosing cholangitis provides a possible link between colonic and biliary duct inflammation.
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Lampinen*1, A. Fredricsson1, J. Vessby1, A. Wanders2, F. Rorsman1, M. Carlson1

Created: Friday, 22 February 2019, 9:49 AM
P039: New molecular markers of the development of ulcerative colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Iakovlev, A.A.(1);Volkov, A.(2);Tarasova, G.(2);Zubova, A.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P039: Suppression of phospholipase A2 of intestinal microbiota by the phospholipid-bile acid conjugate ursodeoxycholate-lysophoshatidylethanolamide ameliorates mucosal inflammation in a genetic mouse model of ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Stremmel W., Staffer S., Stuhrmann N., Gauss A., Burger N., Hornuss D.

Created: Wednesday, 20 February 2019, 10:36 AM
P039: The disappearance of cell death brakes in inflammatory bowel disease: a step towards molecular healing
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Al-Ani, A.(1)*;Samson, A.(2);Rickard, J.(3);Christensen, B.(4);Murphy, J.(2);
Created: Friday, 14 July 2023, 10:48 AM
P039: The role of α4β7+CLA+ ‘dual tropic’ T cells in inflammatory bowel disease
Year: 2022
Source: ECCO'22
Authors: Gordon, H.(1);Rodger, B.(2);Hornsby, E.(2);McGuire, J.(1);Kok, K.B.(1);Lindsay, J.O.(1);Stagg, A.J.(2);
Created: Friday, 11 February 2022, 3:52 PM
P039: Tracking intestinal epithelial cells with fluorescent dyes
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Seidelin*1, F. H. Bergenheim1, O. H. Nielsen1

Created: Friday, 22 February 2019, 9:41 AM
P040 Proteomic characterisation of serum extracellular vesicles in patients with inflammatory bowel diseases: a novel approach for biomarker discovery
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Chaparro1, M. Azkargorta2, A. Lapitz3, L. Ortega-Moreno1, I. Iloro2, A. Arbelaiz3, I. Escobes2, S. Fernández-Tomé1, A.C. Marin1, M. Baldan-Martin1, J.M. Falcon-Perez2, L. Bujanda3, D. Bernardo1, J. Banales3, F. Elortza2, J.P. Gisbert1

Created: Thursday, 30 January 2020, 10:12 AM
P040: Caspase-8 blockade attenuates NSAID-induced colitis and cell death via NLRP3 inflammasome and NF-κB activation
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Singh, R.(1,2);Rossini, V.(1);Stockdale , S.(1);Draper, L.(1);Hill, C.(1,3);Nally, K.(1,4);Shanahan, F.(1);Andersson-Engels, S.(5,6);MelgarPhD, S.(1)*;
Created: Friday, 14 July 2023, 10:48 AM
P040: Intestinal EP4 receptor is required for homeostasis of the colon in mice
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Matsumoto Y., Fukuda A., Seno H.

Created: Wednesday, 20 February 2019, 10:36 AM
P040: Paeoniflorin attenuates ulcerative colitis by inhibiting dendritic cells maturity and Th17/Treg differentiation in naive CD4+ T cells and TNBS-induced Colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

K. Zheng1*, H. Shen1, J. Jia2

Created: Thursday, 21 February 2019, 9:14 AM
P040: Reduced serological response to COVID-19 vaccines in patients with IBD is further diminished by TNF inhibitor therapy; Early results of the VARIATION study (VAriability in Response in IBD Against SARS-COV-2 ImmunisatiON)
Year: 2022
Source: ECCO'22
Authors: Doherty, J.(1);Stack, R.(1);O' Morain, N.(1);Girod, P.(1);Tosetto, M.(1);Inzitari, R.(2);Sheridan, J.(1);Cullen, G.(1);Buckley, M.(3);Mulcahy, H.(1);Ryan, E.J.(4);Daghfal, D.(5);Doran, P.(2);O Morain, C.(6);Doherty, G.(1);
Created: Friday, 11 February 2022, 3:52 PM
P040: The cytokine milieu in patients with inflammatory bowel disease impacts the phenotype of mesenchymal stromal cells
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Barnhoorn*1, K. Schepers2, H. Verspaget1, W. Fibbe2, L. Hawinkels1, M. van Pel2, A. van der Meulen - de Jong1

Created: Friday, 22 February 2019, 9:41 AM
P040: USP16 regulates p65 activation in macrophages and promotes the inflammatory-carcinoma transformation process in IBD patients
Year: 2021
Source: ECCO'21 Virtual
Authors: Zhang, Y.(1);Wang, C.(1);Yao, L.(1);Li, M.(1);Jin, J.(2);Cao, Q.(1);
Created: Wednesday, 2 June 2021, 4:12 PM